ATH 11.1% 0.5¢ alterity therapeutics limited

Presentation today, page-2

  1. 2,786 Posts.
    lightbulb Created with Sketch. 969
    Most of the presentation was, as usual, repeating what has happened. Looks to me that ATH owns more of PBT2, than I thought, they do not talk about charging the royalties at some clear % level, but they will pay to Queensland when ATH gets some money from the patent. I hope I understood this correctly. Nothing about this was told directly. They do not know exactly how to go forward with PBT2, no estimate of the market value of it was told. A deal with a big pharma seems not to be in immediate plans, something needs to be done first with it and they feel that that is not going to cost anything to ATH. Just as was told earlier in December.
    There will be several presentations in congresses, now the MSA conference, AAN conference, and also a conference in the autumn. Mitochondrion studies will be done explaining how ATH434 works (external consultants?) Nothing new from the ape study.
    I would hope there would be some written form about this to check the facts to avoid misunderstandings. Please, correct me if you understood something differently.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $14.25K 2.930M

Buyers (Bids)

No. Vol. Price($)
66 81346070 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19609447 23
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.